| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |